Bridgeway Capital Management’s iSpecimen ISPC Stock Holding History

Bridgeway Capital Management’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-545	Closed	-$23.1K	–	1210
2025 Q1	$23.1K	Hold	545	–	–	﹤0.01%	1151
2024 Q4	$57.9K	Buy	+545	New	+$90.9K	﹤0.01%	1150

Other funds holding ISPC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bridgeway Capital Management's ISPC Position: Q2 2025 in Review

Bridgeway Capital Management sold out of iSpecimen (ISPC) in Q2 2025, closing a stake of 545 shares — an estimated $23.1K sold.

Bridgeway Capital Management first reported a position in ISPC in Q4 2024 and held it in 2 quarters. The position peaked at $57.9K in Q4 2024. 7 funds tracked by Wall St. Rank hold ISPC as of Q2 2025.

Bridgeway Capital Management reported no remaining iSpecimen position as of Q2 2025 after selling out during the quarter.
Bridgeway Capital Management sold 545 iSpecimen shares in Q2 2025, an estimated $23.1K.
Bridgeway Capital Management first reported a position in iSpecimen in Q4 2024 and held it in 2 quarters.
Bridgeway Capital Management's iSpecimen position peaked at $57.9K in Q4 2024.
7 funds tracked by Wall St. Rank held iSpecimen as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.